<DOC>
	<DOCNO>NCT00814645</DOCNO>
	<brief_summary>This study design investigate safety tolerability AIR001 Inhalation Solution administer condition hypoxia identify dose level drug result reduction pulmonary arterial pressure hypoxic condition .</brief_summary>
	<brief_title>Dose-Finding , Safety , Pharmacodynamic Effect Study Sodium Nitrite Inhalation Solution Normal , Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Normal male female volunteer Age 1855 Demonstrate rise pulmonary artery pressure low inspire oxygen concentration ( normal response breathe low level oxygen ) Significant medical illness Risk factor pulmonary hypertension G6PD Cytochrome B5 Reductase deficiencies History form altitude sickness Current prescription counter medication use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>